Prenatal inflammatory risk factors for development of bronchopulmonary dysplasia

Pediatric Pulmonology

Volumn 49, Issue 7, 2014, Pages 665-672

  Eriksson, Lena ^a   Haglund, Bengt ^a   Odlind, Viveca ^b   Altman, Maria ^a   Kieler, Helle ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

diabetes; maternal inflammation; preeclampsia; preterm infants

Indexed keywords

ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CHORIOAMNIONITIS; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INFLAMMATION; INFLAMMATORY DISEASE; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MATERNAL DIABETES MELLITUS; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURITY; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; BRONCHOPULMONARY DYSPLASIA; COMPLICATION; NEWBORN; PREGNANCY COMPLICATION; REGISTER; RISK; STATISTICAL MODEL;

BRONCHOPULMONARY DYSPLASIA; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; LOGISTIC MODELS; MALE; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; REGISTRIES; RISK FACTORS;

EID: 84903398357     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22881     Document Type: Article

References (34)

1. Tibboel D, Jobe AH,. Update in pediatric lung disease 2009. Am J Respir Crit Care Med 2010; 181: 661-665.
2. Coalson JJ,. Pathology of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 179-184.
3. de Kleine MJ, den Ouden AL, Kollee LA, Ilsen A, van Wassenaer AG, Brand R, Verloove-Vanhorick SP,. Lower mortality but higher neonatal morbidity over a decade in very preterm infants. Paediatr Perinat Epidemiol 2007; 21: 15-25.
4. Akram Khan M, Kuzma-O'Reilly B, Brodsky NL, Bhandari V,. Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol 2006; 26: 428-435.
5. Hernandez-Ronquillo L, Tellez-Zenteno JF, Weder-Cisneros N, Salinas-Ramirez V, Zapata-Pallagi JA, da Silva O,. Risk factors for the development of bronchopulmonary dysplasia: A case-control study. Arch Med Res 2004; 35: 549-553.
6. Antonucci R, Contu P, Porcella A, Atzeni C, Chiappe S,. Intrauterine smoke exposure: A new risk factor for bronchopulmonary dysplasia ? J Perinat Med 2004; 32: 272-277.
7. Durrmeyer X, Kayem G, Sinico M, Dassieu G, Danan C, Decobert F,. Perinatal risk factors for bronchopulmonary dysplasia in extremely low gestational age infants: A pregnancy disorder-based approach. J Pediatr 2012; 160: 578-583.e2.
8. Hartling L, Liang Y, Lacaze-Masmonteil T,. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: A systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2012; 97: F8-F17.
9. Garnier Y, Coumans AB, Jensen A, Hasaart TH, Berger R,. Infection-related perinatal brain injury: The pathogenic role of impaired fetal cardiovascular control. J Soc Gynecol Investig 2003; 10: 450-459.
10. Viscardi RM, Muhumuza CK, Rodriguez A, Fairchild KD, Sun CC, Gross GW, Campbell AB, Wilson PD, Hester L, Hasday JD,. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 2004; 55: 1009-1017.
11. Kramer BW, Kallapur S, Newnham J, Jobe AH,. Prenatal inflammation and lung development. Semin Fetal Neonatal Med 2009; 14: 2-7.
12. Jobe AH,. " Miracle" extremely low birth weight neonates: Examples of developmental plasticity. Obstet Gynecol 2010; 116: 1184-1190.
13. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO,. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: 450.
14. Socialstyrelsen. http://www.socialstyrelsen.se/en/Statistics/ statsbysubject/The+Swedish+Hospital+Discharge+Register.htm 2009.
15. Boden R, Lundgren M, Brandt L, Reutfors J, Andersen M, Kieler H,. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: Population based cohort study. Br Med J 2012; 345: e7085.
16. Ozkan H, Cetinkaya M, Koksal N,. Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia. J Matern Fetal Neonatal Med 2012; 25: 2681-2685.
17. Hansen AR, Barnes CM, Folkman J, McElrath TF,. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr 2010; 156: 532-536.
18. Kurkinen-Raty M, Koivisto M, Jouppila P,. Preterm delivery for maternal or fetal indications: Maternal morbidity, neonatal outcome and late sequelae in infants. BJOG 2000; 107: 648-655.
19. Ahmad S, Ahmed A,. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004; 95: 884-891.
20. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA,. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
21. Tjoa ML, Levine RJ, Karumanchi SA,. Angiogenic factors and preeclampsia. Front Biosci 2007; 12: 2395-2402.
22. Stepan H, Faber R, Dornhofer N, Huppertz B, Robitzki A, Walther T,. New insights into the biology of preeclampsia. Biol Reprod 2006; 74: 772-776.
23. Ramma W, Ahmed A,. Is inflammation the cause of pre-eclampsia ? Biochem Soc Trans 2011; 39: 1619-1627.
24. Baker CD, Balasubramaniam V, Mourani PM, Sontag MK, Black CP, Ryan SL, Abman SH,. Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia. Eur Respir J 2012; 40: 1516-1522.
25. Giudice LC, Kao LC,. Endometriosis. Lancet 2004; 364: 1789-1799.
26. Krikun G, Lockwood CJ, Paidas MJ,. Tissue factor and the endometrium: From physiology to pathology. Thromb Res 2009; 124: 393-396.
27. Bental Y, Reichman B, Shiff Y, Weisbrod M, Boyko V, Lerner-Geva L, Mimouni FB,. Impact of maternal diabetes mellitus on mortality and morbidity of preterm infants (24-33 weeks' gestation). Pediatrics 2011; 128: e848-e855.
28. Gasim T,. Gestational diabetes mellitus: Maternal and perinatal outcomes in 220 Saudi women. Oman Med J 2012; 27: 140-144.
29. Ferrazzani S, Luciano R, Garofalo S, D'Andrea V, De Carolis S, De Carolis MP, Paolucci V, Romagnoli C, Caruso A,. Neonatal outcome in hypertensive disorders of pregnancy. Early Hum Dev 2011; 87: 445-449.
30. Thomas W, Speer CP,. Chorioamnionitis: Important risk factor or innocent bystander for neonatal outcome ? Neonatology 2011; 99: 177-187.
31. Mann JR, McDermott S, Gregg A, Gill TJ,. Maternal genitourinary infection and small for gestational age. Am J Perinatol 2009; 26: 667-672.
32. Cnattingius S, Ericson A, Gunnarskog J, Kallen B,. A quality study of a medical birth registry. Scand J Soc Med 1990; 18: 143-148.
33. Altman M,. Moderately preterm infants studies on length of hospital stay and neonatal outcome [thesis for doctoral degree (Ph.JTD)]. Stockholm: Karolinska Institutet; 2011. 63 p.
34. Fellman V, Hellstrom-Westas L, Norman M, Westgren M, Kallen K, Lagercrantz H, Marsal K, Serenius F, Wennergren M,. One-year survival of extremely preterm infants after active perinatal care in Sweden. JAMA 2009; 301: 2225-2233.